Living‐donor kidney transplantation for atypical haemolytic uremic syndrome with pre‐emptive eculizumab use

Publisher： John Wiley & Sons Inc

E-ISSN： 1432-2277|28|3|366-369

ISSN： 0934-0874

Source： TRANSPLANT INTERNATIONAL (ELECTRONIC), Vol.28, Iss.3, 2015-03, pp. : 366-369

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cytomegalovirus post kidney transplantation: prophylaxis versus pre‐emptive therapy?

By  

TRANSPLANT INTERNATIONAL (ELECTRONIC), Vol. 28, Iss. 12, 2015-12 ,pp. : 1351-1356

John Wiley & Sons Inc

Access to resources Recommend Favorite

Evaluation of blood group antibodies in ABO‐incompatible living‐donor kidney transplantation

By  

INTERNATIONAL JOURNAL OF UROLOGY, Vol. 22, Iss. 10, 2015-10 ,pp. : 931-936

John Wiley & Sons Inc

Access to resources Recommend Favorite

Evaluation of blood group antibodies in ABO‐incompatible living‐donor kidney transplantation

By  

INTERNATIONAL JOURNAL OF UROLOGY, Vol. 919-8172, Iss. 10, 2015-10 ,pp. : 931-936

John Wiley & Sons Inc

Access to resources Recommend Favorite

Use of simeprevir following pre‐emptive pegylated interferon/ribavirin treatment for recurrent hepatitis C in living donor liver transplant recipients: a 12‐week pilot study

By  

JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES, Vol. 22, Iss. 2, 2015-02 ,pp. : 144-150

John Wiley & Sons Inc

Access to resources Recommend Favorite

Atypical hemolytic uremic syndrome diagnosed four years after ABO‐incompatible kidney transplantation

By  

NEPHROLOGY, Vol. 20, Iss. S2, 2015-07 ,pp. : 61-65

John Wiley & Sons Inc

Access to resources Recommend Favorite